Realbotix increases private placement to $7-million

Executive Summary

• Realbotix Corp. has upsized its brokered private placement from a previous amount to up to C$7,000,000 due to strong investor demand.
• The offering consists of up to 14 million units priced at C$0.50 per unit, with aggregate gross proceeds of up to C$7 million (approx. US$5 million).
• The units are expected to be subscribed for in full by a single institutional investor, with A.G.P. Canada Investments ULC acting as the sole bookrunner.

Key Details

• Transaction Structure: Brokered private placement pursuant to Part 5A of National Instrument 45-106 and Coordinated Blanket Order 45-935 (Listed Issuer Financing Exemption).
• Units Issued: Up to 14,000,000 units.
• Price: C$0.50 per unit.
• Gross Proceeds: Up to C$7,000,000 (approximately US$5,000,000).
• Subscriber: Expected to be subscribed for in full by a single institutional investor.
• Agent/Bookrunner: A.G.P. Canada Investments ULC.
• Warrant Terms: Each unit includes one common share and one common share purchase warrant.
  • Exercise Price: C$0.75 per share.
  • Term: Five years after the closing date.
  • Ratio: One warrant per unit (entitling holder to acquire one common share).
• Use of Proceeds: Advancing engineering, design, and commercialization of AI-powered humanoid robots; working capital; and general corporate purposes.
• Closing Date: Expected on or about October 24, 2025, subject to regulatory approvals (including conditional acceptance of the TSX Venture Exchange).
• Hold Period: No hold period applies under applicable Canadian securities laws due to the Listed Issuer Financing Exemption.
• Jurisdictions: Offered to residents of Canada (excluding Quebec) and potentially in the United States (Regulation D) and offshore jurisdictions.
• Documentation: Amended and restated offering document dated October 22, 2025, available on SEDAR+ and the company website.